Key result
Novel risk score predicts no-reflow during STEMI PCI with a 0.75 validation AUC.
Why the study?
No-reflow phenomenon during primary PCI is a significant clinical problem in patients with STEMI, but its predictors remain unclear.
Can a risk score based on clinical, angiographic, and procedural features predict no-reflow in STEMI patients undergoing PCI?
Observational (n=1,280)
Can a risk score based on clinical, angiographic, and procedural features predict no-reflow in STEMI patients undergoing PCI?
Effect estimate: AUC 0.75
p-value: p=<0.001
A novel risk score incorporating clinical, angiographic, and procedural variables can predict the no-reflow phenomenon in STEMI patients undergoing primary PCI with acceptable accuracy.
No takes yet. Share an insight, caveat, or question.
May aid no-reflow risk stratification in STEMI PCI; leaves open external validation before clinical adoption.
Бессонов et al. (2020) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=1,280). Risk score for no-reflow phenomenon was evaluated on No-reflow phenomenon (AUC 0.75, p=<0.001). A novel risk score predicted no-reflow in STEMI patients undergoing PCI with an AUC of 0.84 in the training cohort and 0.75 in the validation cohort (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: